Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Peter Gibbs, Cuong Do, Lara Lipton, David N. Cade, Michael J. Tapner, David Price, Geoff D. Bower, Richard Dowling, Meir Lichtenstein, Guy A. van Hazel

ABSTRACT

BACKGROUND: This prospective, open-label phase II study assessed the impact of liver-directed therapy with selective internal radiation therapy (SIRT) and systemic chemotherapy on progression-free survival (PFS) in liver-dominant metastatic pancreatic adenocarcinoma. METHODS: Patients received yttrium-90-labelled ((90)Y) resin microspheres (SIR-Spheres; Sirtex Medical Limited, Sydney, Australia) as a single procedure on day 2 of the first weekly cycle of 5-fluorouracil (5FU; 600 mg/m(2)) with the option to switch to gemcitabine (1000 mg/m(2)) after 8 weeks of 5FU. Statistical analysis was conducted using Microsoft Excel (Microsoft Corporation, Redmond, Washington, USA). The primary endpoint of the study was PFS in the liver, with a median of ≥ 16 weeks defined as the threshold for clinical significance. PFS and overall survival (OS) were summarised by the Kaplan-Meier method using non-parametric estimates of the survivor function. RESULTS: Fourteen eligible patients were enrolled; ten had primary tumour in situ and eight had liver-only metastases. Patients received a median (90)Y activity of 1.1 GBq and 8 weekly doses of 5FU; seven patients received a median of two doses of gemcitabine. Disease control in the liver was 93% (two confirmed partial responses [PR], one unconfirmed PR, ten stable disease). Median reduction in cancer antigen 19-9 was 72%. Median PFS was 5.2 months in the liver, which met the primary endpoint of the study, and 4.4 months at any site. PFS was prolonged in those with a resected primary compared with patients with primary in situ (median 7.8 vs. 3.4 months; p = 0.017). Median OS was 5.5 months overall and 13.6 months in patients with a resected primary. Grade 3/4 adverse events occurred in eight (57%) patients during days 0-60. There was one sudden death and another patient who died from possible treatment-related liver failure 7.0 months after SIRT. CONCLUSIONS: SIRT and chemotherapy appears to be an effective treatment for liver metastases from pancreatic cancer, likely to be of most benefit in selected patients with a resected primary tumour and liver only disease. Significant toxicity was observed and the safety of this approach in patients with metastatic pancreatic cancer will need to be confirmed in subsequent studies. Further study is warranted with SIRT and modern chemotherapies. TRIAL REGISTRATION: ACTRN12606000015549. More... »

PAGES

802

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-015-1822-8

DOI

http://dx.doi.org/10.1186/s12885-015-1822-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036272777

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26503593


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Yttrium Radioisotopes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Western Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417075.0", 
          "name": [
            "Department of Medical Oncology, Royal Melbourne Hospital, Grattan Street, 3050, Parkville, VIC, Australia", 
            "Department of Medical Oncology, Western Hospital, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gibbs", 
        "givenName": "Peter", 
        "id": "sg:person.01343063505.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343063505.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417075.0", 
          "name": [
            "Department of Medical Oncology, Western Hospital, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Do", 
        "givenName": "Cuong", 
        "id": "sg:person.01216064667.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216064667.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417075.0", 
          "name": [
            "Department of Medical Oncology, Royal Melbourne Hospital, Grattan Street, 3050, Parkville, VIC, Australia", 
            "Department of Medical Oncology, Western Hospital, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lipton", 
        "givenName": "Lara", 
        "id": "sg:person.0576053237.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576053237.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sirtex Medical Limited, Sydney, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cade", 
        "givenName": "David N.", 
        "id": "sg:person.01025122047.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025122047.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sirtex Medical Limited, Sydney, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tapner", 
        "givenName": "Michael J.", 
        "id": "sg:person.01136435402.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136435402.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Perth Radiological Clinic, Mount Hospital, Perth, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Price", 
        "givenName": "David", 
        "id": "sg:person.01132603220.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132603220.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Mount Nuclear Medicine, Mount Hospital, Perth, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bower", 
        "givenName": "Geoff D.", 
        "id": "sg:person.013647533071.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013647533071.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Melbourne Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416153.4", 
          "name": [
            "Department of Radiology, Royal Melbourne Hospital, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dowling", 
        "givenName": "Richard", 
        "id": "sg:person.01153545306.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153545306.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Melbourne Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416153.4", 
          "name": [
            "Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lichtenstein", 
        "givenName": "Meir", 
        "id": "sg:person.0650541013.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650541013.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Perth Oncology, Mount Hospital, Perth, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Hazel", 
        "givenName": "Guy A.", 
        "id": "sg:person.0651325573.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651325573.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2009.25.7550", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000628191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.7916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001079421"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002294155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2007.02.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002773475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2008.01.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003261262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2008.05.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003330879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2009.09.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003442138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.24.2446", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004259551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.07.9525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005176755"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31815e4557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007436333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31815e4557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007436333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31815e4557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007436333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31815e4557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007436333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.28.5643", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008247128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.8116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010913317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2011/571261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011522874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(00)01388-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017160303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.0886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019676980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.28.1386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022803629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1011923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022967950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.20141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025193589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.03.056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033172585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040089668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.20073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042069193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.24451", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042501738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2011.02.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044138774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00076-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044922191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.2930420313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046073216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-12-199", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046942754", 
          "https://doi.org/10.1186/1471-2407-12-199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.4433", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047521785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhep.2011.07.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048498474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.06.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048830818"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075175386", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5694/j.1326-5377.2002.tb04886.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075175386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/548.6515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078361977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6092/1590-8577/913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078619781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078623546", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.6.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083106816"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: This prospective, open-label phase II study assessed the impact of liver-directed therapy with selective internal radiation therapy (SIRT) and systemic chemotherapy on progression-free survival (PFS) in liver-dominant metastatic pancreatic adenocarcinoma.\nMETHODS: Patients received yttrium-90-labelled ((90)Y) resin microspheres (SIR-Spheres; Sirtex Medical Limited, Sydney, Australia) as a single procedure on day 2 of the first weekly cycle of 5-fluorouracil (5FU; 600 mg/m(2)) with the option to switch to gemcitabine (1000 mg/m(2)) after 8 weeks of 5FU. Statistical analysis was conducted using Microsoft Excel (Microsoft Corporation, Redmond, Washington, USA). The primary endpoint of the study was PFS in the liver, with a median of \u2265 16 weeks defined as the threshold for clinical significance. PFS and overall survival (OS) were summarised by the Kaplan-Meier method using non-parametric estimates of the survivor function.\nRESULTS: Fourteen eligible patients were enrolled; ten had primary tumour in situ and eight had liver-only metastases. Patients received a median (90)Y activity of 1.1 GBq and 8 weekly doses of 5FU; seven patients received a median of two doses of gemcitabine. Disease control in the liver was 93% (two confirmed partial responses [PR], one unconfirmed PR, ten stable disease). Median reduction in cancer antigen 19-9 was 72%. Median PFS was 5.2 months in the liver, which met the primary endpoint of the study, and 4.4 months at any site. PFS was prolonged in those with a resected primary compared with patients with primary in situ (median 7.8 vs. 3.4 months; p = 0.017). Median OS was 5.5 months overall and 13.6 months in patients with a resected primary. Grade 3/4 adverse events occurred in eight (57%) patients during days 0-60. There was one sudden death and another patient who died from possible treatment-related liver failure 7.0 months after SIRT.\nCONCLUSIONS: SIRT and chemotherapy appears to be an effective treatment for liver metastases from pancreatic cancer, likely to be of most benefit in selected patients with a resected primary tumour and liver only disease. Significant toxicity was observed and the safety of this approach in patients with metastatic pancreatic cancer will need to be confirmed in subsequent studies. Further study is warranted with SIRT and modern chemotherapies.\nTRIAL REGISTRATION: ACTRN12606000015549.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-015-1822-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "name": "Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma", 
    "pagination": "802", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "acc9e9fb6b06d26aeb8f346d4859f50bb80304d38c784f6c7c56625c76746a06"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26503593"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-015-1822-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036272777"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-015-1822-8", 
      "https://app.dimensions.ai/details/publication/pub.1036272777"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000550.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12885-015-1822-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1822-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1822-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1822-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1822-8'


 

This table displays all metadata directly associated to this object as RDF triples.

298 TRIPLES      21 PREDICATES      76 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-015-1822-8 schema:about N13ca68d5275e481cbc310d1718721ed5
2 N178b9489a4bd47c688b6f796c6db8711
3 N20562cddf20c4a10aab1b820046f5a8b
4 N4710f2bbfccc409186c8cdad9464e91a
5 N4ad0acf878304d2ea325ae8203add835
6 N6129e20c7e2b4755869e1530c7655649
7 N73a94e6465f14f76a23fe8374876a508
8 N7f913229f1844930aa601a32fc87bf30
9 Nb8def594b90f47bfae81ed9abebee6b6
10 Nccd18761e88244adaf01d6fa7ca90c9d
11 Ne380c7a1dbaf4ffa8c22b0314941e190
12 Nfda648ec5fe2474ab1bab8ef74aa4d67
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nf551ec51fbb94f41892409973511679b
16 schema:citation sg:pub.10.1186/1471-2407-12-199
17 https://app.dimensions.ai/details/publication/pub.1075175386
18 https://app.dimensions.ai/details/publication/pub.1078623546
19 https://doi.org/10.1002/cncr.23339
20 https://doi.org/10.1002/cncr.23685
21 https://doi.org/10.1002/hep.24451
22 https://doi.org/10.1002/jso.20141
23 https://doi.org/10.1002/jso.2930420313
24 https://doi.org/10.1016/j.ijrobp.2007.03.056
25 https://doi.org/10.1016/j.jhep.2011.07.012
26 https://doi.org/10.1016/j.jvir.2007.02.019
27 https://doi.org/10.1016/j.jvir.2008.01.009
28 https://doi.org/10.1016/j.jvir.2008.05.013
29 https://doi.org/10.1016/j.jvir.2011.02.023
30 https://doi.org/10.1016/s0360-3016(00)01388-2
31 https://doi.org/10.1016/s0959-8049(02)00076-x
32 https://doi.org/10.1053/j.gastro.2009.09.006
33 https://doi.org/10.1056/nejmoa1011923
34 https://doi.org/10.1097/coc.0b013e31815e4557
35 https://doi.org/10.1155/2011/571261
36 https://doi.org/10.1177/548.6515
37 https://doi.org/10.1200/jco.1997.15.6.2403
38 https://doi.org/10.1200/jco.2005.06.023
39 https://doi.org/10.1200/jco.2006.07.9525
40 https://doi.org/10.1200/jco.2006.08.7916
41 https://doi.org/10.1200/jco.2006.09.0886
42 https://doi.org/10.1200/jco.2008.20.8116
43 https://doi.org/10.1200/jco.2009.24.2446
44 https://doi.org/10.1200/jco.2009.25.4433
45 https://doi.org/10.1200/jco.2009.25.7550
46 https://doi.org/10.1200/jco.2010.28.1386
47 https://doi.org/10.1200/jco.2010.28.5643
48 https://doi.org/10.3322/caac.20073
49 https://doi.org/10.5694/j.1326-5377.2002.tb04886.x
50 https://doi.org/10.6092/1590-8577/913
51 schema:datePublished 2015-12
52 schema:datePublishedReg 2015-12-01
53 schema:description BACKGROUND: This prospective, open-label phase II study assessed the impact of liver-directed therapy with selective internal radiation therapy (SIRT) and systemic chemotherapy on progression-free survival (PFS) in liver-dominant metastatic pancreatic adenocarcinoma. METHODS: Patients received yttrium-90-labelled ((90)Y) resin microspheres (SIR-Spheres; Sirtex Medical Limited, Sydney, Australia) as a single procedure on day 2 of the first weekly cycle of 5-fluorouracil (5FU; 600 mg/m(2)) with the option to switch to gemcitabine (1000 mg/m(2)) after 8 weeks of 5FU. Statistical analysis was conducted using Microsoft Excel (Microsoft Corporation, Redmond, Washington, USA). The primary endpoint of the study was PFS in the liver, with a median of ≥ 16 weeks defined as the threshold for clinical significance. PFS and overall survival (OS) were summarised by the Kaplan-Meier method using non-parametric estimates of the survivor function. RESULTS: Fourteen eligible patients were enrolled; ten had primary tumour in situ and eight had liver-only metastases. Patients received a median (90)Y activity of 1.1 GBq and 8 weekly doses of 5FU; seven patients received a median of two doses of gemcitabine. Disease control in the liver was 93% (two confirmed partial responses [PR], one unconfirmed PR, ten stable disease). Median reduction in cancer antigen 19-9 was 72%. Median PFS was 5.2 months in the liver, which met the primary endpoint of the study, and 4.4 months at any site. PFS was prolonged in those with a resected primary compared with patients with primary in situ (median 7.8 vs. 3.4 months; p = 0.017). Median OS was 5.5 months overall and 13.6 months in patients with a resected primary. Grade 3/4 adverse events occurred in eight (57%) patients during days 0-60. There was one sudden death and another patient who died from possible treatment-related liver failure 7.0 months after SIRT. CONCLUSIONS: SIRT and chemotherapy appears to be an effective treatment for liver metastases from pancreatic cancer, likely to be of most benefit in selected patients with a resected primary tumour and liver only disease. Significant toxicity was observed and the safety of this approach in patients with metastatic pancreatic cancer will need to be confirmed in subsequent studies. Further study is warranted with SIRT and modern chemotherapies. TRIAL REGISTRATION: ACTRN12606000015549.
54 schema:genre research_article
55 schema:inLanguage en
56 schema:isAccessibleForFree true
57 schema:isPartOf Nbc3aa3d3bdb0443397b6fb610d52e30d
58 Ne32a72af1e9546eaaf9716db37d864bf
59 sg:journal.1024632
60 schema:name Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma
61 schema:pagination 802
62 schema:productId N080d96cb386148bd82b29859a816ddee
63 N2faebb5601f144a69bed4efdbae434a4
64 Nbe03a9a0462c4812bb4dd8122073d9b3
65 Ne79c1251bd3e4a04a004a06df80d140c
66 Ne90b85c30078403b9277cb9f4e1e8807
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036272777
68 https://doi.org/10.1186/s12885-015-1822-8
69 schema:sdDatePublished 2019-04-10T23:31
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher Nc3da705371554fb4b93aba21257c7525
72 schema:url http://link.springer.com/10.1186%2Fs12885-015-1822-8
73 sgo:license sg:explorer/license/
74 sgo:sdDataset articles
75 rdf:type schema:ScholarlyArticle
76 N080d96cb386148bd82b29859a816ddee schema:name readcube_id
77 schema:value acc9e9fb6b06d26aeb8f346d4859f50bb80304d38c784f6c7c56625c76746a06
78 rdf:type schema:PropertyValue
79 N13ca68d5275e481cbc310d1718721ed5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Humans
81 rdf:type schema:DefinedTerm
82 N178b9489a4bd47c688b6f796c6db8711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Male
84 rdf:type schema:DefinedTerm
85 N182518d50f01461dae2820dcd64545d8 schema:name Perth Radiological Clinic, Mount Hospital, Perth, Australia
86 rdf:type schema:Organization
87 N20562cddf20c4a10aab1b820046f5a8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Aged
89 rdf:type schema:DefinedTerm
90 N2faebb5601f144a69bed4efdbae434a4 schema:name doi
91 schema:value 10.1186/s12885-015-1822-8
92 rdf:type schema:PropertyValue
93 N323dd5531c424bb9841618a9ac440ebd rdf:first sg:person.01216064667.32
94 rdf:rest N7bd2aaa784a94ffdbc5f1d071a99c5bb
95 N370efbaa8a0e4779bd484041dfb52efc rdf:first sg:person.01132603220.32
96 rdf:rest N4524edf5c66d45cc83c358effe49ae6e
97 N39df29e0eb8941efb6b7122f6c2ddbb2 schema:name Sirtex Medical Limited, Sydney, Australia
98 rdf:type schema:Organization
99 N4524edf5c66d45cc83c358effe49ae6e rdf:first sg:person.013647533071.12
100 rdf:rest Ne58ea448ca544e04a366d270e9127946
101 N4710f2bbfccc409186c8cdad9464e91a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Antimetabolites, Antineoplastic
103 rdf:type schema:DefinedTerm
104 N4ad0acf878304d2ea325ae8203add835 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Combined Modality Therapy
106 rdf:type schema:DefinedTerm
107 N5a77581d6a514aa08871f55c7f82d2ca schema:name Perth Oncology, Mount Hospital, Perth, Australia
108 rdf:type schema:Organization
109 N6129e20c7e2b4755869e1530c7655649 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Yttrium Radioisotopes
111 rdf:type schema:DefinedTerm
112 N73a94e6465f14f76a23fe8374876a508 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Middle Aged
114 rdf:type schema:DefinedTerm
115 N7bd2aaa784a94ffdbc5f1d071a99c5bb rdf:first sg:person.0576053237.67
116 rdf:rest Na8b67819a11a4af9b2a0f9f082daf362
117 N7f913229f1844930aa601a32fc87bf30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Female
119 rdf:type schema:DefinedTerm
120 N872a5415568149f6a23e6d72fe1db9e9 schema:name Mount Nuclear Medicine, Mount Hospital, Perth, Australia
121 rdf:type schema:Organization
122 N8d99a61038ef42068e4e2ad81066cfb3 rdf:first sg:person.01136435402.10
123 rdf:rest N370efbaa8a0e4779bd484041dfb52efc
124 Na1a622c0c7d447e082c459cbbb70cccc rdf:first sg:person.0651325573.37
125 rdf:rest rdf:nil
126 Na8b67819a11a4af9b2a0f9f082daf362 rdf:first sg:person.01025122047.29
127 rdf:rest N8d99a61038ef42068e4e2ad81066cfb3
128 Nb3ff419ec9fe460d8f305dce14932f4f schema:name Sirtex Medical Limited, Sydney, Australia
129 rdf:type schema:Organization
130 Nb8def594b90f47bfae81ed9abebee6b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Liver Neoplasms
132 rdf:type schema:DefinedTerm
133 Nbc3aa3d3bdb0443397b6fb610d52e30d schema:volumeNumber 15
134 rdf:type schema:PublicationVolume
135 Nbe03a9a0462c4812bb4dd8122073d9b3 schema:name nlm_unique_id
136 schema:value 100967800
137 rdf:type schema:PropertyValue
138 Nc3da705371554fb4b93aba21257c7525 schema:name Springer Nature - SN SciGraph project
139 rdf:type schema:Organization
140 Nccd18761e88244adaf01d6fa7ca90c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Prospective Studies
142 rdf:type schema:DefinedTerm
143 Nd771eb83382e4d48bade1d1e02a72c46 rdf:first sg:person.0650541013.49
144 rdf:rest Na1a622c0c7d447e082c459cbbb70cccc
145 Ne32a72af1e9546eaaf9716db37d864bf schema:issueNumber 1
146 rdf:type schema:PublicationIssue
147 Ne380c7a1dbaf4ffa8c22b0314941e190 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Pancreatic Neoplasms
149 rdf:type schema:DefinedTerm
150 Ne58ea448ca544e04a366d270e9127946 rdf:first sg:person.01153545306.66
151 rdf:rest Nd771eb83382e4d48bade1d1e02a72c46
152 Ne79c1251bd3e4a04a004a06df80d140c schema:name dimensions_id
153 schema:value pub.1036272777
154 rdf:type schema:PropertyValue
155 Ne90b85c30078403b9277cb9f4e1e8807 schema:name pubmed_id
156 schema:value 26503593
157 rdf:type schema:PropertyValue
158 Nf551ec51fbb94f41892409973511679b rdf:first sg:person.01343063505.31
159 rdf:rest N323dd5531c424bb9841618a9ac440ebd
160 Nfda648ec5fe2474ab1bab8ef74aa4d67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Fluorouracil
162 rdf:type schema:DefinedTerm
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
167 schema:name Oncology and Carcinogenesis
168 rdf:type schema:DefinedTerm
169 sg:journal.1024632 schema:issn 1471-2407
170 schema:name BMC Cancer
171 rdf:type schema:Periodical
172 sg:person.01025122047.29 schema:affiliation Nb3ff419ec9fe460d8f305dce14932f4f
173 schema:familyName Cade
174 schema:givenName David N.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025122047.29
176 rdf:type schema:Person
177 sg:person.01132603220.32 schema:affiliation N182518d50f01461dae2820dcd64545d8
178 schema:familyName Price
179 schema:givenName David
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132603220.32
181 rdf:type schema:Person
182 sg:person.01136435402.10 schema:affiliation N39df29e0eb8941efb6b7122f6c2ddbb2
183 schema:familyName Tapner
184 schema:givenName Michael J.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136435402.10
186 rdf:type schema:Person
187 sg:person.01153545306.66 schema:affiliation https://www.grid.ac/institutes/grid.416153.4
188 schema:familyName Dowling
189 schema:givenName Richard
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153545306.66
191 rdf:type schema:Person
192 sg:person.01216064667.32 schema:affiliation https://www.grid.ac/institutes/grid.417075.0
193 schema:familyName Do
194 schema:givenName Cuong
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216064667.32
196 rdf:type schema:Person
197 sg:person.01343063505.31 schema:affiliation https://www.grid.ac/institutes/grid.417075.0
198 schema:familyName Gibbs
199 schema:givenName Peter
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343063505.31
201 rdf:type schema:Person
202 sg:person.013647533071.12 schema:affiliation N872a5415568149f6a23e6d72fe1db9e9
203 schema:familyName Bower
204 schema:givenName Geoff D.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013647533071.12
206 rdf:type schema:Person
207 sg:person.0576053237.67 schema:affiliation https://www.grid.ac/institutes/grid.417075.0
208 schema:familyName Lipton
209 schema:givenName Lara
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576053237.67
211 rdf:type schema:Person
212 sg:person.0650541013.49 schema:affiliation https://www.grid.ac/institutes/grid.416153.4
213 schema:familyName Lichtenstein
214 schema:givenName Meir
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650541013.49
216 rdf:type schema:Person
217 sg:person.0651325573.37 schema:affiliation N5a77581d6a514aa08871f55c7f82d2ca
218 schema:familyName van Hazel
219 schema:givenName Guy A.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651325573.37
221 rdf:type schema:Person
222 sg:pub.10.1186/1471-2407-12-199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046942754
223 https://doi.org/10.1186/1471-2407-12-199
224 rdf:type schema:CreativeWork
225 https://app.dimensions.ai/details/publication/pub.1075175386 schema:CreativeWork
226 https://app.dimensions.ai/details/publication/pub.1078623546 schema:CreativeWork
227 https://doi.org/10.1002/cncr.23339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002294155
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1002/cncr.23685 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040089668
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1002/hep.24451 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042501738
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1002/jso.20141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025193589
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1002/jso.2930420313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046073216
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.ijrobp.2007.03.056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033172585
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.jhep.2011.07.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048498474
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.jvir.2007.02.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002773475
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/j.jvir.2008.01.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003261262
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/j.jvir.2008.05.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003330879
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.jvir.2011.02.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044138774
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/s0360-3016(00)01388-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017160303
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/s0959-8049(02)00076-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044922191
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1053/j.gastro.2009.09.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003442138
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1056/nejmoa1011923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022967950
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1097/coc.0b013e31815e4557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007436333
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1155/2011/571261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011522874
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1177/548.6515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078361977
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1200/jco.1997.15.6.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083106816
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1200/jco.2005.06.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048830818
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1200/jco.2006.07.9525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005176755
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1200/jco.2006.08.7916 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001079421
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1200/jco.2006.09.0886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019676980
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1200/jco.2008.20.8116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010913317
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1200/jco.2009.24.2446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004259551
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1200/jco.2009.25.4433 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047521785
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1200/jco.2009.25.7550 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000628191
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1200/jco.2010.28.1386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022803629
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1200/jco.2010.28.5643 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008247128
284 rdf:type schema:CreativeWork
285 https://doi.org/10.3322/caac.20073 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042069193
286 rdf:type schema:CreativeWork
287 https://doi.org/10.5694/j.1326-5377.2002.tb04886.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1075175386
288 rdf:type schema:CreativeWork
289 https://doi.org/10.6092/1590-8577/913 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078619781
290 rdf:type schema:CreativeWork
291 https://www.grid.ac/institutes/grid.416153.4 schema:alternateName Royal Melbourne Hospital
292 schema:name Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Australia
293 Department of Radiology, Royal Melbourne Hospital, Melbourne, Australia
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.417075.0 schema:alternateName Western Hospital
296 schema:name Department of Medical Oncology, Royal Melbourne Hospital, Grattan Street, 3050, Parkville, VIC, Australia
297 Department of Medical Oncology, Western Hospital, Melbourne, Australia
298 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...